1. Medtech Insight
  2. >>Minute Insights

Minute Insight: Medtronic Received Medicare Coverage For New MiniMed 780G Insulin Pump

 
• By Marion Webb

Medtronic has secured coverage to market its recently approved MiniMed 780G insulin pump to eligible Medicare and Medicare Advantage beneficiaries, opening access to more patients after a long delay in bringing the device to the US market.

Minute Insight
• Source: Citeline/Alamy

Medtronic plc said it secured extended coverage from the US Centers for Medicare & Medicaid Services for its newly launched MiniMed 780G insulin pump. The company plans to process orders immediately and start shipments over the coming weeks.

The extended coverage for eligible Medicare and Medicare Advantage beneficiaries clears yet another hurdle in Medtronic’s efforts to bring its next-generation MiniMed 780G,which pairs with the Guardian 4 sensor, to “as many people as possible,” Ali Dianaty, Medtronic’s senior vice president of Product Innovation and Operations, told

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Minute Insights

Minute Insight: Haemonetics Buys OpSens To Add Fiber-Optic Sensors For Intervention

 
• By Reed Miller

Haemonetics will acquire Quebec-based OpSens for CAD $2.90 per share, or about US $253m at current exchange rates. Haemonetics expects OpSens' fiber-optic technology to complement its interventional cardiology portfolio.

Minute Insight: Best Buy Will Sell Dexcom CGM

 
• By Reed Miller

The retail giant will sell the Dexcom G7 continuous glucose monitoring system to eligible customers through a new online platform.

Minute Insight: Stimdia Starts Trial Of Phrenic Nerve Stimulator For Patients On Ventilators

 
• By Barnaby Pickering

Stimdia is trying to restore respiratory function in ICU patients with phrenic nerve stimulation.

Minute Insight: Medtronic May Sell Respiratory And Monitoring Units To Private Equity

 
• By Reed Miller

Reuters reported that global private equity firm Carlyle Group has offered to pay at least $7bn for Medtronic’s patient monitoring and respiratory interventions businesses. Medtronic announced its plan to get out of those businesses about one year ago.

More from Medtech Insight

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.

MORE Details On MHRA’s Online Platform For Post Market Surveillance

 
• By Ashley Yeo

Post-market surveillance regulations for medtech system users in Great Britain coming into force on 16 June will make new data requirements under new compliance deadlines.

23andMe Purchase Will Let Regeneron Scale Drug Development

 
• By Alaric DeArment

The consumer genomics firm will operate as a subsidiary, while Regeneron plans to leverage its database for drug discovery and trial design efforts.